Circulating Melatonin Levels: Possible Link Between Parkinson’s Disease and Cancer Risk?

By Schernhammer Eva   Chen Honglei   Ritz Beate  

Cancer Causes and Control, Vol. 17, Iss. 4, 2006-05 ,pp. : 577-582

Springer Publishing Company

Access to resources Recommend Favorite

Are we missing the mTOR target in breast cancer?

By Johnston Stephen  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 607-611

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life in randomized trials of cytotoxic or hormonal treatment of advanced breast cancer. Is there added value?

By Fossati Roldano  

Breast Cancer Research and Treatment, Vol. 87, Iss. 3, 2004-10 ,pp. : 233-243

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy?

By Pritchard Kathleen  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 587-588

Springer Publishing Company

Access to resources Recommend Favorite

Hormonal Factors and Breast Tumor Proliferation: Do Factors that Affect Cancer Risk also Affect Tumor Growth?

By Oestreicher Nina   White Emily   Malone Kathleen   Porter Peggy  

Breast Cancer Research and Treatment, Vol. 85, Iss. 2, 2004-05 ,pp. : 133-142

Springer Publishing Company

Access to resources Recommend Favorite